{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T17:24:13Z","timestamp":1782494653393,"version":"3.54.5"},"reference-count":45,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T00:00:00Z","timestamp":1757030400000},"content-version":"am","delay-in-days":369,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["T32CA193111"],"award-info":[{"award-number":["T32CA193111"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pancreatology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.pan.2024.06.004","type":"journal-article","created":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T22:51:00Z","timestamp":1718232660000},"page":"887-893","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["The impact of metastatic sites on survival Rates and predictors of extended survival in patients with metastatic pancreatic cancer"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9951-667X","authenticated-orcid":false,"given":"Jonah M.","family":"Levine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0257-1654","authenticated-orcid":false,"given":"Ingmar F.","family":"Rompen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3912-8746","authenticated-orcid":false,"given":"Jorge Campos","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Swett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian C.","family":"Kryschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph R.","family":"Habib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Diskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Brock","family":"Hewitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1205-6477","authenticated-orcid":false,"given":"Greg D.","family":"Sacks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0686-5544","authenticated-orcid":false,"given":"Brian","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russel S.","family":"Berman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher L.","family":"Wolfgang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammar A.","family":"Javed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pan.2024.06.004_bib1","series-title":"Cancer Facts & Figures\u00a02023. Journal [serial online]","author":"Society","year":"2023"},{"issue":"4","key":"10.1016\/j.pan.2024.06.004_bib2","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s11605-022-05476-w","article-title":"Tailoring Adjuvant chemotherapy to biologic response following neoadjuvant chemotherapy impacts overall survival in pancreatic cancer","volume":"27","author":"Ghabi","year":"2023","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"6","key":"10.1016\/j.pan.2024.06.004_bib3","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/SLA.0000000000005708","article-title":"Persistent circulating tumor cells at 1 year after oncologic resection predict late recurrence in pancreatic cancer","volume":"277","author":"Javed","year":"2023","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.pan.2024.06.004_bib4","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.21037\/jgo-20-426","article-title":"Favorable tumor biology in locally advanced pancreatic cancer-beyond CA19-9","volume":"12","author":"Kinny-K\u00f6ster","year":"2021","journal-title":"J\u00a0Gastrointest Oncol"},{"issue":"5","key":"10.1016\/j.pan.2024.06.004_bib5","doi-asserted-by":"crossref","DOI":"10.3892\/or.2021.8182","article-title":"Metastatic pancreatic cancer: Mechanisms and detection","volume":"46","author":"Chen","year":"2021","journal-title":"Oncol Rep"},{"issue":"1","key":"10.1016\/j.pan.2024.06.004_bib6","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cell.2011.11.025","article-title":"EMT and dissemination Precede pancreatic tumor formation","volume":"148","author":"Rhim","year":"2012","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.pan.2024.06.004_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18071338","article-title":"Pancreatic ductal adenocarcinoma: current and Evolving therapies","volume":"18","author":"Adamska","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"27","key":"10.1016\/j.pan.2024.06.004_bib8","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1200\/JCO.20.01364","article-title":"Metastatic pancreatic cancer: ASCO guideline Update","volume":"38","author":"Sohal","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"issue":"20","key":"10.1016\/j.pan.2024.06.004_bib9","first-page":"6461","article-title":"Currently Debated Topics on surgical treatment of pancreatic ductal adenocarcinoma: a Narrative review on surgical treatment of borderline resectable, locally advanced, and synchronous or metachronous oligometastatic tumor","volume":"12","author":"Pedrazzoli","year":"2023","journal-title":"J\u00a0Clin Med"},{"issue":"38","key":"10.1016\/j.pan.2024.06.004_bib10","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000004861","article-title":"Long-term results of intraoperative electron beam radiation therapy for nonmetastatic locally advanced pancreatic cancer: retrospective cohort study, 7-year experience with 247 patients at the National Cancer Center in China","volume":"95","author":"Chen","year":"2016","journal-title":"Medicine (Baltim)"},{"issue":"6","key":"10.1016\/j.pan.2024.06.004_bib11","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/jso.24402","article-title":"Prognostic value of occult tumor cells obtained by peritoneal lavage in patients with resectable pancreatic cancer and no ascites: a systematic review","volume":"114","author":"Steen","year":"2016","journal-title":"J\u00a0Surg Oncol"},{"issue":"6","key":"10.1016\/j.pan.2024.06.004_bib12","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/jso.24723","article-title":"Microscopic lymphovascular invasion is an independent predictor of survival in resected pancreatic ductal adenocarcinoma","volume":"116","author":"Epstein","year":"2017","journal-title":"J\u00a0Surg Oncol"},{"issue":"1","key":"10.1016\/j.pan.2024.06.004_bib13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/SLA.0000000000004915","article-title":"Surgical decision-making in pancreatic ductal adenocarcinoma: Modeling prognosis following Pancreatectomy in the Era of induction and Neoadjuvant chemotherapy","volume":"277","author":"Habib","year":"2023","journal-title":"Ann Surg"},{"key":"10.1016\/j.pan.2024.06.004_bib14","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.suronc.2019.08.010","article-title":"Oligometastatic pulmonary metastasis in pancreatic cancer patients: safety and outcome of resection","volume":"31","author":"Ilmer","year":"2019","journal-title":"Surg Oncol"},{"issue":"3","key":"10.1016\/j.pan.2024.06.004_bib15","first-page":"E48","article-title":"Pulmonary metastases in pancreatic cancer, is there a survival influence?","volume":"6","author":"Deeb","year":"2015","journal-title":"J\u00a0Gastrointest Oncol"},{"issue":"1","key":"10.1016\/j.pan.2024.06.004_bib16","doi-asserted-by":"crossref","first-page":"88","DOI":"10.21037\/hbsn-22-489","article-title":"Liver metastasis of pancreatic cancer: the new choice at the crossroads","volume":"12","author":"Liu","year":"2023","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"5","key":"10.1016\/j.pan.2024.06.004_bib17","doi-asserted-by":"crossref","first-page":"548","DOI":"10.4161\/cbt.4.5.1663","article-title":"Immortalizing the complexity of cancer metastasis: genetic features of lethal metastatic pancreatic cancer obtained from rapid autopsy","volume":"4","author":"Embuscado","year":"2005","journal-title":"Cancer Biol Ther"},{"issue":"3","key":"10.1016\/j.pan.2024.06.004_bib18","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.pan.2021.01.014","article-title":"The impact of different metastatic patterns on survival in patients with pancreatic cancer","volume":"21","author":"He","year":"2021","journal-title":"Pancreatology"},{"issue":"10","key":"10.1016\/j.pan.2024.06.004_bib19","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.3748\/wjg.v23.i10.1872","article-title":"Prognostic value of site-specific metastases in pancreatic adenocarcinoma: a Surveillance Epidemiology and End Results database analysis","volume":"23","author":"Oweira","year":"2017","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.pan.2024.06.004_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2022.100388","article-title":"Prognosis and tumor biology of pancreatic cancer patients with isolated lung metastases: translational results from the German multicenter AIO-YMO-PAK-0515 study","volume":"7","author":"Kruger","year":"2022","journal-title":"ESMO Open"},{"key":"10.1016\/j.pan.2024.06.004_bib21","doi-asserted-by":"crossref","DOI":"10.1097\/SLA.0000000000006142","article-title":"Progression of site-specific Recurrence of pancreatic cancer and Implications for treatment","author":"Rompen","year":"2023","journal-title":"Ann Surg"},{"key":"10.1016\/j.pan.2024.06.004_bib22","article-title":"A\u00a0population-based study of synchronous distant metastases and prognosis in patients with PDAC at initial diagnosis","volume":"13","author":"Zhang","year":"2023","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.pan.2024.06.004_bib23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1756-8722-2-13","article-title":"Long term survivors with metastatic pancreatic adenocarcinoma treated with gemcitabine: a retrospective analysis","volume":"2","author":"Goulart","year":"2009","journal-title":"J\u00a0Hematol Oncol"},{"issue":"5","key":"10.1016\/j.pan.2024.06.004_bib24","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.7314\/APJCP.2012.13.5.1841","article-title":"Long term survivors with metastatic pancreatic cancer treated with gemcitabine alone or plus cisplatin: a retrospective analysis of an Anatolian Society of Medical Oncology multicenter study","volume":"13","author":"Inal","year":"2012","journal-title":"Asian Pac J Cancer Prev APJCP"},{"issue":"7","key":"10.1016\/j.pan.2024.06.004_bib25","doi-asserted-by":"crossref","DOI":"10.1097\/MPA.0000000000000163","article-title":"Clinical characteristics of long-term survivors of inoperable pancreatic cancer: an 8-year cohort analysis in Korea","volume":"43","author":"Jo","year":"2014","journal-title":"Pancreas"},{"issue":"4","key":"10.1016\/j.pan.2024.06.004_bib26","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/1536867X0200200401","article-title":"Using Aalen's linear hazards model to investigate time-varying effects in the proportional hazards regression model","volume":"2","author":"Hosmer","year":"2002","journal-title":"STATA J"},{"issue":"2","key":"10.1016\/j.pan.2024.06.004_bib27","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1634\/theoncologist.2014-0394","article-title":"Prognostic factors of survival in a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic pancreatic cancer","volume":"20","author":"Tabernero","year":"2015","journal-title":"Oncol"},{"issue":"3\u20134","key":"10.1016\/j.pan.2024.06.004_bib28","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000313532","article-title":"Treatment of metachronous and simultaneous liver metastases of pancreatic cancer","volume":"44","author":"D\u00fcnschede","year":"2010","journal-title":"Eur Surg Res"},{"issue":"2","key":"10.1016\/j.pan.2024.06.004_bib29","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ejso.2016.10.023","article-title":"Radical surgery of oligometastatic pancreatic cancer","volume":"43","author":"Hackert","year":"2017","journal-title":"Eur J Surg Oncol"},{"issue":"5","key":"10.1016\/j.pan.2024.06.004_bib30","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/jhbp.1127","article-title":"Outcomes of lung metastasis from pancreatic cancer: a nationwide multicenter analysis","volume":"29","author":"Homma","year":"2022","journal-title":"J\u00a0Hepato-Biliary-Pancreatic Sci"},{"issue":"4","key":"10.1016\/j.pan.2024.06.004_bib31","doi-asserted-by":"crossref","DOI":"10.1097\/SLA.0000000000002600","article-title":"Predictors of Resectability and survival in patients with borderline and locally advanced pancreatic cancer who underwent Neoadjuvant treatment with FOLFIRINOX","volume":"269","author":"Michelakos","year":"2019","journal-title":"Ann Surg"},{"issue":"8","key":"10.1016\/j.pan.2024.06.004_bib32","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1056\/NEJMc1107627","article-title":"FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer","volume":"365","author":"Vaccaro","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.pan.2024.06.004_bib33","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s12032-012-0361-2","article-title":"FOLFIRINOX for locally advanced and metastatic pancreatic cancer: single institution retrospective review of efficacy and toxicity","volume":"30","author":"Gunturu","year":"2012","journal-title":"Med Oncol"},{"issue":"4\u20136","key":"10.1016\/j.pan.2024.06.004_bib34","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1159\/000351442","article-title":"Surgery for colorectal liver metastases","volume":"30","author":"McNally","year":"2013","journal-title":"Dig Surg"},{"issue":"6","key":"10.1016\/j.pan.2024.06.004_bib35","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s00423-012-0959-z","article-title":"Long-term outcomes after surgical resection for gastric cancer liver metastasis: an analysis of 64 macroscopically complete resections","volume":"397","author":"Takemura","year":"2012","journal-title":"Langenbeck's Arch Surg"},{"issue":"1","key":"10.1016\/j.pan.2024.06.004_bib36","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.surg.2016.02.019","article-title":"Synchronous resections of hepatic oligometastatic pancreatic cancer: Disputing a principle in a time of safe pancreatic operations in a retrospective multicenter analysis","volume":"160","author":"Tachezy","year":"2016","journal-title":"Surgery"},{"issue":"8","key":"10.1016\/j.pan.2024.06.004_bib37","doi-asserted-by":"crossref","DOI":"10.1097\/MPA.0000000000001133","article-title":"Long-term survivors of pancreatic cancer: a California population-based study","volume":"47","author":"Kardosh","year":"2018","journal-title":"Pancreas"},{"issue":"1","key":"10.1016\/j.pan.2024.06.004_bib38","doi-asserted-by":"crossref","DOI":"10.1097\/SLA.0000000000003859","article-title":"Prognosis based Definition of Resectability in pancreatic cancer: a Road Map to new guidelines","volume":"275","author":"Oba","year":"2022","journal-title":"Ann Surg"},{"issue":"12","key":"10.1016\/j.pan.2024.06.004_bib39","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1080\/00365520510023819","article-title":"Gemcitabine treatment in patients with inoperable locally advanced\/metastatic pancreatic cancer and prognostic factors","volume":"40","author":"Sezgin","year":"2005","journal-title":"Scand J Gastroenterol"},{"issue":"8","key":"10.1016\/j.pan.2024.06.004_bib40","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1007\/s11605-022-05320-1","article-title":"Socioeconomic predictors of access to care for patients with Operatively managed pancreatic cancer in New York state","volume":"26","author":"Thomas","year":"2022","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"2","key":"10.1016\/j.pan.2024.06.004_bib41","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/SLA.0b013e3180691579","article-title":"National failure to operate on early stage pancreatic cancer","volume":"246","author":"Bilimoria","year":"2007","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.pan.2024.06.004_bib42","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1177\/1758834015579313","article-title":"Systemic therapy in stage IV pancreatic cancer: a population-based analysis using the National Cancer Data Base","volume":"7","author":"Khanal","year":"2015","journal-title":"Ther Adv Med Oncol"},{"issue":"7","key":"10.1016\/j.pan.2024.06.004_bib43","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1007\/s11605-019-04311-z","article-title":"Disparities in the Use of chemotherapy in patients with resected pancreatic ductal adenocarcinoma","volume":"24","author":"Wright","year":"2020","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"2","key":"10.1016\/j.pan.2024.06.004_bib44","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1245\/s10434-020-08717-x","article-title":"Racial Disparity in Pancreatoduodenectomy for borderline resectable pancreatic adenocarcinoma","volume":"28","author":"Molina","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.pan.2024.06.004_bib45","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.amjsurg.2018.12.007","article-title":"Healthcare disparities in outcomes of patients with resectable pancreatic cancer","volume":"217","author":"Moaven","year":"2019","journal-title":"Am J Surg"}],"container-title":["Pancreatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1424390324006598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1424390324006598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T20:46:26Z","timestamp":1728333986000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1424390324006598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S1424390324006598"],"URL":"https:\/\/doi.org\/10.1016\/j.pan.2024.06.004","relation":{},"ISSN":["1424-3903"],"issn-type":[{"value":"1424-3903","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of metastatic sites on survival Rates and predictors of extended survival in patients with metastatic pancreatic cancer","name":"articletitle","label":"Article Title"},{"value":"Pancreatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pan.2024.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 IAP and EPC. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}